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Abstract
Purpose γ-Aminobutyric acid (GABA) is recognised as a potential metabolic bioactive food ingredient with increasing evidence
of its effects on the gut-brain axis and systemic metabolic health. Different lactic acid bacteria are capable of producing GABA,
particularly strains of Lactobacillus brevis. In this study, we characterized a Lb. brevis isolated from traditional alpine cheese (Lb.
brevis DSM 32386) for its ability to accumulate high levels of GABA in the culture medium and for other important probiotic
phenotypic traits.
Methods In vitro analysis were used to study the Lb. brevis DSM 32386 probiotic traits and the gene expression involved in
GABA production
Result Lactobacillus brevis DSM 32386 converted monosodium glutamate to GABA more efficiently than the type strain Lb.
brevis DSM 20054, resulting in more than 200% of GABA produced. This ability seemed to be related to the higher transcrip-
tional activation of the gene encoding for the glutamate (gad) decarboxylase antiporter (gadC) and regulator (gadR).
Lactobacillus brevis DSM 32386 performed well in vitro under the stress conditions mimicking the gastro-intestinal tract, being
resistant to acid pH (pH 2.5) and growing in simulated pancreatic fluid and 0.3% ox-bile.
Conclusion These preliminary studies indicate that Lb. brevis DSM 32386 holds promise as a starter for GABA-rich dairy
fermented foods and possibly a promising next-generation probiotic microorganism in the context of the gut (microbiota):brain axis.
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Introduction
Formulation of the neurotransmitter γ-aminobutyric acid
(GABA)–enriched foods or functional foods capable of
delivery GABA is an opening research and development target
for the food industry. These foods include dairy products, soy-
bean, kimchi and juice products (Inoue et al. 2003; Hayakawa
et al. 2004; Park and Oh 2007; Kim et al. 2009; Chang et al.
2009; Gangaraju et al. 2014). Moreover, the isolation of
GABA-producing strains from diverse fermented food and
from the human gut is providing considerable natural biotech-
nological solutions for efficacious functional food design
(Komatsuzaki et al. 2005; Siragusa et al. 2007; Hiraga et al.
2008; Li et al. 2008). Those isolates could represent next-
generation probiotics with specific mode of action based
around their GABA-producing capability and possible modu-
lation of the gut:brain axis (Bravo et al. 2011; Forsythe and
Kunze 2013).
As defined by the Food and Agriculture Organization
and the World Health Organization, probiotics are “live
microorganisms which when administered in adequate
amounts confer a health benefit on the host”. Other
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definitions advanced through the years have been restric-
tive by specification of mechanisms, site of action, deliv-
ery format (e.g. food) or host (Hill et al. 2014). To accu-
mulate in the intestinal tract, probiotics must first survive
the various conditions specific to the digestive system,
such as low pH in the stomach and the presence of bile
acids in the intestines: these represent important selection
criteria for putative probiotics (Kimoto-Nira et al. 2015).
Probiotic efficacy has been shown to be species- and even
strain-dependent since different bacterial strains can affect
host via different modes of action (Maassen and Claassen
2008; Cani and Van Hul 2015). With a growing emphasis
on demonstrating probiotic health effects, rational selec-
tion of probiotic strains based on their ability to modulate
very specific physiological traits e.g. BSH activity, GABA
or bacteriocin production, is becoming a prerequisite for
probiotic selection.
Several GABA-producing LAB species isolated from
traditional fermented food and beverages have been report-
ed. These include Lb. paracasei (Komatsuzaki et al. 2005,
2008; Siragusa et al. 2007), Lb. buchneri (Cho et al. 2007;
Park and Oh 2007; Zhao et al. 2015), Lactococcus lactis
(Nomura et al. 1998; Siragusa et al. 2007), Lb. delbrueckii
subsp. bulgaricus (Siragusa et al. 2007), Lb. plantarum
(Siragusa et al. 2007) and Lb. brevis (Ueno et al. 1997;
Yokoyama et al. 2002; Park and Oh 2007; Siragusa et al.
2007; Li et al. 2008; Zhang et al. 2012). Cheese represents
a rich source of LAB with potential GABA-producing
properties (Nomura et al. 1998; Siragusa et al. 2007;
Franciosi et al. 2015). The results of these findings offer
potential alternatives to take advantage of GABA’s health
benefits through GABA-enriched cheeses. In a previous
work, we isolated 276 strains from a specific raw cow milk
“Nostrano-cheese”, typical of the Trentino province (north,
Alpine area) in Italy. Among those, 71% bacterial strains
were able to produce GABA (Franciosi et al. 2015) and, in
particular, the Lb. brevis DSM 32386 possessed the highest
GABA-producing rate (Franciosi et al. 2015; Carafa et al.
2019). In this work, we characterized the genetic basis of
DSM 32386 strain’s GABA production, as well as we
assessed some characteristics considered important for pro-
biotic selection, making it a good candidate as a starter of
ingredient for functional GABA-enriched foods.
Material and methods
Reagents
All media constituents were purchased from Oxoid Ltd.
(Basingstoke, UK) and Sigma Aldrich (Milan, Italy),
chemicals were purchased from Sigma Aldrich.
Bacterial strains, culture medium and growth
conditions
The stock culture collection of Lb. brevis DSM 32386
(Fondazione Edmund Mach collection and deposited at
Leibniz-Institut DSMZ, Germany) and DSM 20054
(Leibniz-Institut DSMZ, Germany), as well as of Lb.
delbrueckii subs. lactis LL199 from the Department of Food
and Drug Science—University of Parma collection (Belletti
et al. 2009), were maintained at − 80 °C in 20% v/v glycerol.
Bacterial cells were propagated twice in MRS broth by incu-
bation at 37 °C for 16 h before each experiments.
γ-Aminobutyric acid (GABA) production
and quantification
Glutamate decarboxylase (GAD) activity of Lb. brevis DSM
32386 and the production of GABAwere measured as report-
ed by Nomura et al. (Nomura et al. 1999). Briefly, Lb. brevis
DSM 32386 and DSM 20054 were grown in MRS for 24 h at
37 °C temperature. Cell cultures were then centrifuged (8600
rcf for 15 min at 4 °C), washed twice with sterile PBS, and
suspended in sterile 0.85% w/v NaCl solution in order to
achieve the A620 nm value of 2.5. One hundred microliters
of cell suspension was then mixed with 900 μL of 50 mM
sodium acetate buffer (pH 4.7) containing 7.0 mM L-gluta-
mate and 0.1 mM pyridoxal phosphate. The reaction mixture
was incubated for 24 h at 37 °C and filtered through a
0.22-μm pore size filter (Minisart, Sartorius Stedim Biotech,
Goettingen, Germany). The sample, diluted 10 times with
sodium tetraborate 0.1 M (pH adjusted to 10.5) and added to
glycine, as internal standard to a final concentration of 10 mg/
L, was stored at − 20 °C before the analysis. L-Glutamic acid,
glycine, and GABA were quantified as o-phthalaldehyde
(OPA) adducts. The detection limit for GABAwas estimated
at 0.025 mg/L (three times the standard deviation of the
GABA contents measured repeating ten times the analysis of
a sample at unquantifiable content).
GAD genes sequencing
DNA was extracted with QIAamp DNA Blood Mini Kit
(QIAGEN, Milan, Italy) from Lb. brevis DSM 32386 over-
night broth culture following the manufacturer protocol. PCR
amplification for the GABA genetic locus (gadR, gadA, gadC
and gadB) was performed by using of specific primers (see
Supplementary Table S1). PCR reactions were carried out in a
2720 Applied Biosystems Thermal Cycler (Applied
Biosystems, Foster City, CA, USA). Amplified products were
subsequently purified using the Promega PCR and Gel Clean
Up system kit according to the manufacturer’s instructions
(Promega Corporation, Milan, Italy). Sequencing was carried
out by Sequencing Platform Unit, Fondazione Edmund Mach
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(San Michele a/A, Trento, Italy). The identifications were re-
fined by BLAST (1 www.ncbi.nlm.nih.gov/BLAST) and
Clustal Omega (www.ebi.ac.uk/Tools/msa/clustalo/)
alignment of the GAD DNA sequences to the reference
genome.
GAD genes expression
Lactobacillus brevisDSM 32386 and DSM 20054 were inoc-
ulated in MRS in the presence or absence of 30 mg/mL of
monosodium glutamate (MSG) for 12 h. Total RNAwas ex-
tracted from cultures at 0, 3, 7 and 12 h using TriZol®
(LifeTechnologies, Monza, Italy), according to the manufac-
turer’s instructions, then samples were reverse transcribed
using SensiFAST cDNA Synthesis Kit (BioLine
AUROGENE s.r.l., Rome, Italy). The expression of target
genes (gadR, gadA, gadB and gadC) was quantified by quan-
titative Real Time PCR (Supplementary Table S2). The assay
was performed using 2× qPCRBIO SyGreen mix
(PCRBIOSYSTEM, Resnova S.r.l., Rome, Italy) and carried
out with a LightCycler 480 (Roche, LifeScience, Italy). The
housekeeping gene tuf1 was used to normalize the expression
of target genes. The comparative critical threshold method
(2−ΔΔCt) was used to calculate the relative gene expression
with respect to time 0. The RT-qPCR was performed in dupli-
cates for each cDNA sample and independent experiments
were carried out in triplicates.
Tolerance to pH, oxbile and pancreatic fluid
Effect of low pH was studied by the method of Tsai et al.
2008. Briefly, one millilitre of culture containing about 109
CFU/mL of LAB was transferred into 9 ml phosphate-
buffered saline (PBS; NaCl, 137 mM/L; KCl, 2.7 mM/L;
Na2HPO4, 10 mM/L; KH2PO4, 1.8 mM/L). The pH was ad-
justed to 2.0, 2.5 and 3.2 using 0.1 N HCl and cells incubated
at 37 °C for 3 h. Control was performed at pH 7.2. After
incubation, serial dilution plating onMRS agar was performed
to determine viable bacterial counts. Plates were incubated
anaerobically at 37 °C for 48 h and acid tolerance was esti-
mated by comparing the viable LAB bacteria counts in MRS
agar for surviving cells. Data are presented as log(CFU/mL) ±
standard deviation. Five independent experiments were
performed.
Tolerance for bile acids was performed on LAB cells ex-
posed to low pH. After the 3-h treatment described above,
cells were centrifuged (5000g, 5 min), washed with PBS
(pH 7.2) and then grown in 9 mLMRS broth with and without
0.3% (w/v) Oxgall bile for 3, 12 and 24 h. Bile tolerance was
estimated by comparing the viable LAB bacteria count in
MRS with and without bile salt. Data are presented as
log(CFU/mL) ± standard deviation. Three independent exper-
iments were performed.
Tolerance for pancreatic fluid was tested by inoculating
actively growing bacteria (10% v/v inoculum size) to the test
medium [150 mM NaHCO3 and 1.9 mg/mL pancreatin
(Sigma, USA); pH 8.0]. The cultures were kept for 3 h in a
shaking water bath (Certomat WR, B. Braun, Melsungen,
Germany) at 37 °C. Survival of LAB strains was examined
by plating onMRS agar after 0, and 3 h of incubation. Data are
presented as log(CFU/mL) ± standard deviation. Three inde-
pendent experiments were performed.
Antibiotic susceptibility test
Lactobacillus brevisDSM 32386 and DSM 20054 phenotypic
antibiotic resistance to ampicillin, vancomycin, gentamicin,
erythromycin, clindamycin and tetracycline was assessed
using the strip test M.I.C. Evaluator (Oxoid Ltd.,
Basingstoke, UK) following the manufacturer’s instruction.
The strips consist of a gradient of stabilised antimicrobial cov-
ering 15 doubling dilutions. M.I.C.E. strips were used on a
pre-inoculated agar plate, with formation of defined concen-
tration gradient in the area around it. Minimum Inhibitory
Concentration (MIC) was determined at the border of growth
inhibition around the strip. Values were compared to the
guidelines for facultative heterofermentative lactobacilli as in-
dicated in the “Guidance on the assessment of bacterial sus-
ceptibility to antimicrobials of human and veterinary impor-
tance” by the European Food Safety Authority (EFSA) (EFSA
Panel on Additives and Products or Substances used in
Animal Feed (FEEDAP) 2012).
Detection of antibiotic resistance genes
Genomic DNA from overnight cultures of Lb. brevis DSM
32386, Lb. brevisDSM 20054 and Lb. delbrueckii subs. lactis
LL199 was extracted with QIAamp DNA Blood Mini Kit
(QIAGEN, Milan, Italy). Polymerase chain reactions was
used to determine antibiotic resistance genes by gene-
specific primers (Table 4), by using genomic DNA from Lb.
delbrueckii subs. lactis resistant strain LL199 as positive con-
trol. After an initial denaturation step of 94 °C for 5 min, the
amplification programme consisted of 35 cycles of: 94 °C for
1 min, annealing temperature (Table 4) for 1 min, 72 °C for 2
min. PCR reactions were carried out in a 2720 Applied
Biosystems Thermal Cycler (Applied Biosystems, Foster
City, CA, USA) and amplicons were analysed on 1% agarose
gel to confirm presence and fragment size.
Statistics
Paired t test was used to compare differences between the
effect of a particular stress condition and the control, or be-
tween different gene expression levels. The level of signifi-
cance was set at p < 0.05.
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Results
Lb. brevis DSM 32386 GABA production
Our previous study identified several cheese isolates capable
of producing GABA (Franciosi et al. 2015). Starting from this
preliminary information, we focused on Lb. brevis DSM
32386. Firstly, the GABA production rate of Lb. brevis
DSM 32386 was compared to that of the type strain Lb. brevis
DSM 20054. After incubation at 37 °C for 24 h, DSM 32386
was able to produce considerable higher quantity of GABA
(262.06 ± 15.42 mg/L) compared to the type strain (78.27 ±
18.61 mg/L) (p < 0.00001).
Two different GAD encoding genes have been character-
ized in different Lb. brevis stains, namely gadA and gadB
(Nomura et al. 1998; Siragusa et al. 2007; Komatsuzaki
et al. 2008; Hiraga et al. 2008). gadA is located adjacent to
and downstream of the glutamate/GABA antiporter gene
(gadC), commonly referred as gadCA. They form an operon
with the operon regulator gadR, being immediately upstream
of gadCA. gadB is located separately from the other gad genes
(Li et al. 2013) (Fig. 1A). By the use of fourteen sets of
primers based on the nucleotidic sequence of the reference
strain ATCC367 (Supplementary Table S1), the DSM 32386
operon and gadB sequences were amplified confirming the
presence of each genetic locus involved in the GABA produc-
tion within DSM 32386 strain. The gene sequences shared
high similarity with the ATCC367 strain, revealing the ab-
sence of any polymorphisms in the operon system or in the
antiporter. We thus asked whether this high ability was related
to an increase in gene expression of such genes in the presence
of glutamate. The RT-qPCR analysis of gad genes showed a
different expression profile in Lb. brevis DSM 32386 and
DSM 20054 genes, both in the presence or absence of the
operon inducer glutamate (Fig. 1B). With the exception of
gadA after 7 h and gadC after 12 h, gad genes are repressed
in the absence of glutamate, while the presence of glutamate
induced their expression in both strains. All gad genes were
up-regulated to a greater degree by DSM 32386 than in the
type strain (gadA, p < 0.001; gadB, p < 0.001;gadC, p < 0.01;
gadR, p < 0.01), especially after 7 h of growth (Fig. 1B).
Lb. brevis DSM 32386 tolerance to simulated
gastrointestinal conditions
One of the characteristics required for being a probiotic is the
ability to survive the gastrointestinal (GI) physiochemical en-
vironment. Therefore the Lb. brevis DSM 32386 tolerance to
acid pH, bile and pancreatic fluid, mimicking the acidic and
liptolytic environment present along the GI tract was mea-
sured. Lb. brevis DSM 32386 was more resistant to acid pH
than the type strain DSM 20054, being able to survive to 3 h
exposure at pH 2.5 and 3.2, but not to pH 2.0 (Table 1).
Moreover, incubation of DSM 32386 strain in growthmedium
containing pancreatic fluid had no effect on its viability and
fitness (Table 1). The type strain DSM 20054 behaved in a
similar manner and not statistically significant differences
were observed between the survivals of both strains in pan-
creatic fluid (Table 1).
Subsequently DSM 32386 cells that survived pH 2.5 (3 h)
acid treatment were cultured in MRS broth in the presence or
absence of 0.3% Oxbile. Lb. brevis DSM 32386 cells were
able to resist to bile salts, even with a significant cell reduction
over time (Table 2). DSM 32386 cells surviving the pH 2.5
acid treatment grew at rate comparable to the not pH-treated
cells when transferred into MRS broth (Table 2).
Antibiotic susceptibility testing
Regarding the safety assurance of probiotic organisms in food,
FAO/WHO guidelines (2002) suggest testing probiotic strains
for antibiotic resistance. Primary testing of the antibiotic resis-
tance patterns of Lb. brevis DSM 32386 and DSM 20054
strains was carried out by the E-strip method, following man-
ufacturer’s instruction. According to the sensitivity guidelines
provided by EFSA (EFSA Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP) 2012), DSM
32386 was interpreted to be sensitive to vancomycin,
clindamycin, tetracycline, ampicillin and erythromycin, while
resistant to gentamycin with MIC being two times more the
indicated cut off value (Table 3). Instead, DSM 20054 was
interpreted to be sensitive to vancomycin, tetracycline, ampi-
cillin and erythromycin and resistant to gentamycin and
clindamycin with MICs being four and sixteen times more
the indicated cut-off values (Table 3).
We therefore analysed the presence of the antibiotic resis-
tance cassettes at the genomic level by PCR (Table 4) using
Lb. delbrueckii subs. lactis LL199 as positive control, as al-
ready reported resistant to clindamycin, tetracycline, erythro-
mycin and gentamycin (Belletti et al. 2009). Only the eryth-
romycin resistance gene erm(A) and tetracycline cassette
tet(W) were detected in both Lb. brevis strains, while
clindamycin, ampicillin and gentamycin resistance genes
were not detectable.
Discussion and conclusion
The identification of strains with specific mode of action or
biochemical traits capable of mediating specific host physio-
logical responses represents the basis of a rational scientific
selection of the next generation probiotic strains designed to
mediate specific health effects in the host.
High γ-aminobutyric acid (GABA)–producing LAB
strains isolated from fermented food, including cheese
(Siragusa et al. 2007; Franciosi et al. 2015) and fresh
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unpasteurizedmilk (Fan et al. 2011) or by strains isolated from
the human intestinal tract represent a rich and natural
bioresource for identification of putative probiotic (Monte
et al. 2009; Settanni and Moschetti 2010; Montel et al.
2014). GABA is produced primarily from the irreversible α-
decarboxylation of L-glutamate by the enzyme glutamate de-
carboxylase (GAD) (Cotter and Hill 2003). In the intracellular
glutamate decarboxylase (GAD) system, glutamate is
imported into cells by the GABA antiporter, decarboxylated
by intracellular GAD to produce GABA and subsequently
GABA is exported from the cells via the antiporter (Sanders
et al. 1998; Small and Waterman 1998; Li et al. 2013). Two
GAD-encoding genes, named gadA and gadB are present in
Lb. brevis (Li et al. 2013; Wu and Shah 2016; Yunes et al.
2016; Wu et al. 2017; Wu and Shah 2018). The high GABA
production by Lb. brevisDSM 32386 appears not to be due to
mutation in these genes as we identified the presence of the
intact gad operon at the genomic level. In general, the bacte-
rial GAD system includes (i) a glutamate uptake by a specific
transporter followed by (ii) the removal of an intracellular
proton during glutamate decarboxylation and (iii) GABA ex-
port from the cell via an antiporter. This leads to an increase in
the cytoplasmic pH (by the removal of hydrogen ions) and
also slightly increasing the extracellular pH (by the exchange
of extracellular glutamate for GABA) (Cotter and Hill 2003;
Wu et al. 2017). Interestingly, compared to the type strain
DSM 20054, Lb. brevis DSM 32386 induces a higher expres-
sion of both gadA and gadB genes over time, accompanied by
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Fig. 1 GAD system in Lb. brevis
and genes expression in response
to 30 mg/ml of monosodium glu-
tamate. (A) The gad operon genes
and gadB gene in Lb. brevis; (B)
RT-qPCR has been used to assess
the transcription level of the gad
in DSM 32386 and DSM 20054
as described in ‘Material and
methods’ section. Comparative
critical threshold method
(2−ΔΔCt) was used to calculate
the relative gene expression with
respect to time 0. Data are pre-
sented as mean ± sd, N = 3. *p <
0.05, **p < 0.01, paired t test,
DSM 32386 relative expression
vs DSM 20054 relative
expression
Table 1 Analysis of acid and pancreatic fluid tolerance Lb. brevis DSM 32386 and Lb. brevis DSM 20054
Strain Acid tolerance (pH 2.0, 2.5 and 3.2) Resistance to pancreatic fluid
0 h pH 7.2, 3 h pH 3.2, 3 h pH 2.5, 3 h pH 2, 3 h 0 h 3 h
DSM 32386 9.64 ± 0.40a 9.09 ± 0.21 8.85 ± 0.64 7.75 ± 0.74 nd 7.84 ± 0.56a 7.92 ± 0.45
DSM 20054 9.87 ± 0.70 8.61 ± 0.22 8.43 ± 0.37 n.d n.d 8.11 ± 1.13 7.90 ± 0.51
a Bacterial counts are converted to log CFU/ml
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an increased level of gadC, the gene encoding for the
antiporter and gadR, encoding for the positive operon regula-
tor. Indeed, the higher activation of the GAD system observed
could account for the high GABA production.
The physiological activity of GABA makes it an interesting
bioactive molecule which has already been used as a food sup-
plement in pure form (Andrighetto et al. 2002). In recent years,
researchers have reported a number of placebo controlled stud-
ies in which GABAwas administered as a food or oral supple-
ment to healthy participants (Am et al. 2005; Nakamura et al.
2009; Kanehira et al. 2011; Yoto et al. 2012; Li et al. 2015;
Steenbergen et al. 2015). A pioneering study in patients with
mild hypertension reported that daily intake of fermented milk
containing 10–12 mg/100 mL of GABA could significantly
lower blood pressure within 2 weeks (Inoue et al. 2003). In
these terms, fermented milk enriched in GABA produced by
Lb. brevis DSM 32386 may have commercial potential as a
health-oriented dairy product as well as any direct probiotic
effect of the high GABA-producing strain.
To be considered a possible probiotic, the bacterial strain,
in addition to being a GRAS organism, should be able to
survive within the human GI tract and therein mediate a spe-
cific health-related activity in the right environment (Lee and
Salminen 1995; Salminen et al. 1998). Testing for tolerance of
low pH, bile acids and pancreatic fluids have often been con-
sidered as good indicators for survival through the GI tract. In
this study, Lb. brevisDSM 32386 strain performed well in the
in vitro tests, and survival through the stomach is likely. In
addition, previous studies have shown that food matrix plays
an important role in probiotic survival of gastric pH
(Charalampopoulos et al. 2003; Stadler and Viernstein 2003;
Mancini Andrea 2017) and cheeses in particular appears to
effectively protect probiotics from low pH encountered in
the stomach (Boylston et al. 2004). However, survival under
in vivo conditions in human subjects should be tested.
Lactic acid bacteria are intrinsically resistant to many anti-
biotics (Delgado et al. 2005; Fukao et al. 2009; Devirgiliis
et al. 2013; Guo et al. 2017; Campedelli et al. 2019). In many
cases, resistances are not, however, transmissible, and the spe-
cies are also sensitive to many clinically used antibiotics even
in the case of a lactic acid bacteria–associated opportunistic
infection. Among 187 isolates, from 55 European probiotic
products showed that 79% of the isolates were resistant to
kanamycin and 65% of the isolates were vancomycin resis-
tant. Remaining resistances were in the order of tetracycline
(26%), penicillin G (23%), erythromycin (16%) and chloram-
phenicol (11%). Overall, 68.4% of the isolates showed resis-
tance against multiple antibiotics including intrinsic resistance
(Temmerman et al. 2003). The antimicrobial susceptibility
tests indicated that Lb. brevis DSM 32386 was resistant to
gentamycin, and the type strain DSM 20054 as resistant to
gentamycin and clindamycin. In general, Lactobacillus spe-
cies are intrinsically resistant to aminoglycosides such as gen-
tamicin, with resistance reported in strains isolated from dif-
ferent sources, as in the case of Lb. brevis isolated from
fermented vegetables (Abriouel et al. 2015). EFSA requires
the assessment of antibiotic resistance in strain introduced in
the food chain, with particular attention in distinguishing be-
tween bacterial species with “intrinsic resistance” or “acquired
resistance”. Since intrinsic resistance is specific for a bacterial
species or genus, when all strains within a given taxonomic
group show phenotypic resistance to an antimicrobial, this
resistance can be considered intrinsic to the taxonomic group
(EFSA Panel on Additives and Products or Substances used in
Animal Feed (FEEDAP) 2012). In our study, gentamicin re-
sistance was detected in both Lb. brevis DSM 32386 and
Table 2 Effect of bile salts on Lb.
brevis DSM 32386 after low pH
treatment
Time (h) 0 3 12 24
MRS 5.38 ± 0.79b 4.16 ± 0.45 6.29 ± 0.51 8.55 ± 0.37
MRS + oxbilea 5.78 ± 1.13 2.03 ± 1.3* 2.3 ± 1.41** 3.12 ± 1.55***
aMRS + oxbile means MRS broth with 0.3% Oxgall
b Bacteria counts are converted to log CFU/ml
*p < 0.05
**p < 0.01
***p < 0.001, paired t test, oxbile vs none
Table 3 Resisance of Lb. brevis
DSM 32386 and Lb. brevis DSM
20054 to various antimicrobial
agents
CA VA DA TE AM ER
Cut-off value (μg/ml)a 16 2 1 8 4 1
DSM 32386 MIC (μg/ml) 32 – 0.03 4 2 0.25
DSM 20054 MIC (μg/ml) 64 – 16 4 2 0.5
aMicrobiological cut-off values as indicated by EFSA; CA, Gentamycin; VA, Vancomycin; DA, Clindamycin;
TE, Tetracycline; AM, Ampicillin; ER, Erythromycin
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20054 strains, being more evident in the type strains, thus
allowing us to consider it as natural and not acquired antibiotic
resistance, therefore no particular safety concern is associated
with this intrinsic type of resistance.
From a molecular point of view, any gentamicin amplicons
was evidenced by PCR, while Lb. brevis strains harboured the
erm(A) and tet(W) cassette, respectively, for erythromycin and
tetracycline resistance, that were phenotypically confirmed
but they were below the EFSA cut-off values. In
Lactobacillus ssp., the most common erm cassette is erm(B)
also detected in Lb. brevis, while erm(A) is rarely found
(Nawaz et al. 2011). Genes that confer tetracycline resistance
in lactobacilli can be tet(S), (W), (K), (L) and (O), widely
distributed between species and mainly represented in Lb.
brevis by tet(M) and tet(S) (Fukao et al. 2009; Nawaz et al.
2011; Devirgiliis et al. 2013; Campedelli et al. 2019). A more
comprehensive overview and information on the genetic basis
of Lb. brevis DSM 32386 antibiotic resistance will be derived
by genome sequencing that represent the further step in the
study of this strain.
Even though in vivo investigations are needed, alto-
gether these preliminary results showed that the Lb. brevis
GABA producing DSM 32386 strain represents a promis-
ing starter for manufacturing GABA-rich cultured dairy
foods to be used as functional food as well as a promising
next generat ion probiot ic in the context of the
gut(microbiota):brain axis. Tests on GABA level avail-
ability in DSM 32386 dairy products are ongoing.
Overall, our data indicate the importance of studying and
preserving the traditional raw milk cheese microbiome.
Traditional cheeses represent an important source of mi-
crobial biodiversity where new LAB strains with potential
health-promoting properties can be isolated.
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Table 4 Gene specific primers and condition for PCR reactions
Antibiotic Antibiotic resistance
cassette
Primers 5′-3′ Annealing
temperatures (°C)
Size
(bp)
References
Ampicillin mecA CGTSTTTAACTAAGTATSGY
GGGATCATAGCGTCATTATTC
58 1429 Guo et al. (2017)
bla TAGGTTCAGATTGGCCCTTAG
CATARTTCCGATAATASMGCC
51 297 Guo et al. (2017)
claZ GCATGRTAACCATCACAWAC
ACTTCAACACCTGCTGCTTTC
58 240 Guo et al. (2017)
Erythromycin erm(A) AAGCGGTAAACCCCTCTGA
TTCGCAAATCCCTTCTCAAC
55 190 Nawaz et al. (2011)
erm(B) GAAAAGRTACTCAACCAAATA
AGTAACGGTACTTAAATTGTTTAC
52 642 Nawaz et al. (2011)
Gentamycin aac CCAAGAGCAATAAGGGCATA
CACTATCATAACCACTACCG
60 220 Nawaz et al. (2011)
Clindamycin lun(A) GCTAATATTGTTTAAATCGTCAAT
GGTGGCTGGGGGGTAGATGTATTAACTGG
55 323 Guo et al. (2017)
lun(B) GCTTCTTTTGAAATACATGGTATTTTTCGATC
CCTACCTATTGTTTGTGGAA
54 925 Guo et al. (2017)
Tetracycline tetM1 GCTTGATCCCCAGTAAGTCA
GGTGAACATCATAGACACGC
55 401 Guo et al. (2017)
tetL1 GTMGTTGCGCGCTATATTCC
GTGAAMGRWAGCCCACCTAA
55 696 Fukao et al. (2009)
tet(W) GAGAGCCTGCTATATGCCAGC GGGCGTAT
CCACAATGTTAAC
64 168 Fukao et al. (2009)
tet(S) ATCAAGATATTAAGGAC
TTCTCTATGTGGTAATC
56 573 Nawaz et al. (2011)
tet(L) CATTTGGTCTTATTGGATCG
ATTACACTTCCGATTTCGG
50 456 Nawaz et al. (2011)
tet(K) TTAGGTGAAGGGTTAGGTCC
GCAAACTCATTCCAGAAGCA
55 697 Nawaz et al. (2011)
tet(O) AACTTAGGCATTCTGGCTCAC
TCCCACTGTTCCATATCGTCA
52 515 Nawaz et al. (2011)
tet(Q) AGAATCTGCTGTTTGCCAGTG
CGGAGTGTCAATGATATTGCA
56 169 Nawaz et al. (2011)
tet(M) GTTAAATAGTGTTCTTGGAG
CTAAGATATGGCTCTAACAA
55 576 Nawaz et al. (2011)
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